Acutaas Chemicals Limited announced its Q2 and H1 FY27 financial results, reporting a robust 42.7% year-on-year revenue growth to ₹4,369 million for the quarter ended September 30, 2026. Profit After Tax (PAT) saw an impressive 71.4% increase to ₹1,231 million. The company also highlighted the inauguration of its South Korea manufacturing facility and revised its FY27 revenue growth guidance upwards.
Acutaas Chemicals Reports Strong Q2 FY27 Performance
Acutaas Chemicals Limited has announced its financial results for the second quarter and half-year ended September 30, 2026. The company reported a significant increase in revenue from operations, reaching ₹4,369 million for Q2 FY27, a 42.7% rise compared to the same period last year. Profit After Tax (PAT) for the quarter also saw substantial growth, up 71.4% to ₹1,231 million, with PAT margins standing at 28.2%.
Key Financial Highlights (Q2 FY27 Consolidated)
- Revenue from operations: ₹4,369 million (up 42.7% YoY)
- Gross Profit: ₹2,715 million (up 59.0% YoY)
- Gross Margin: 62.1%
- EBITDA: ₹1,760 million (up 84.6% YoY)
- EBITDA Margin: 40.3%
- PAT: ₹1,231 million (up 71.4% YoY)
- PAT Margin: 28.2%
H1 FY27 Performance
For the half-year ended September 30, 2026, Acutaas Chemicals reported revenue from operations of ₹7,666 million, representing a 49.3% increase year-on-year. EBITDA for H1 FY27 stood at ₹2,890 million (up 97.7% YoY), and PAT was ₹1,981 million (up 71.0% YoY).
Strategic Developments and Future Outlook
Mr. Naresh Patel, Executive Chairman & Managing Director, commented on the strong performance, attributing the revenue growth to the momentum in the Pharmaceutical Intermediates business. A key milestone was the inauguration of the company’s South Korea manufacturing facility ahead of schedule, which is equipped to produce high-purity chemicals for the semiconductor industry. Based on improved revenue visibility and a robust order pipeline, Acutaas Chemicals has revised its FY27 revenue growth guidance upward from 25% to around 30% and its EBITDA margin guidance to the 38-40% range.
About Acutaas Chemicals Limited
Acutaas Chemicals Limited is a speciality chemicals manufacturer serving diverse industries including pharmaceuticals, semiconductors, and battery chemicals. The company focuses on research-driven development and manufacturing of advanced pharmaceutical intermediates and is expanding its portfolio to include high-value speciality chemicals for emerging technologies.
Source: BSE
